Sign in

CIK 0001610853

  • Non-accelerated filer
  • Smaller reporting company
Ticker
HSDT
Exchange
Nasdaq
Industry
Finance Services
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364787690
Phone
+1 215-944-6100
Business address
1650 MARKET STREET, SUITE 3600, PHILADELPHIA, PA, 19103
Former names
HELIUS MEDICAL TECHNOLOGIES, INC., HELIUS MEDICAL TECHNOLOGIES, INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy President and CEO bought 158,868 shares at an average $0.54 ($85,033)
  4. 4 Open-market buy President and CEO bought 100,000 shares at an average $0.64 ($63,501)
  5. 4 Grant or award Director acquired 6,049 shares (grant or award)
  6. 4 Grant or award Director acquired 6,049 shares (grant or award)
  7. 4 Grant or award Director acquired 6,049 shares (grant or award)
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award Director acquired 6,049 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award CFO and Treasurer acquired 8,011 shares (grant or award)
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy President and CEO bought 5,100 shares at $5.25 ($26,789)
  14. 4 Open-market buy CFO and Treasurer bought 3,000 shares at $5.31 ($15,929)
  15. 4 Open-market buy President and CEO bought 37,500 shares at $8.00 ($300,000)
  16. 4 Open-market buy President and CEO bought 10,000 shares at $14.72 ($147,222)
  17. 4 Grant or award Director acquired 721 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market buy President and CEO bought 10,000 shares at $14.96 ($149,629)
  20. 4 Open-market buy President and CEO bought 10,450 shares at an average $14.84 ($155,097)

Page 4 of 11 · 217 filings